BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 32972176)

  • 1. Arterial hypertension and COVID-19 infections: A brief commentary.
    Widimský J
    Vnitr Lek; 2020; 66(3):104-106. PubMed ID: 32972176
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of antihypertensive agents on clinical course and in-hospital mortality: analysis of 169 hypertensive patients hospitalized for COVID-19.
    Kocayigit I; Kocayigit H; Yaylaci S; Can Y; Erdem AF; Karabay O
    Rev Assoc Med Bras (1992); 2020; 66Suppl 2(Suppl 2):71-76. PubMed ID: 32965360
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Related molecular mechanisms of COVID-19, hypertension, and diabetes.
    Akkus E; Sahin M
    Am J Physiol Endocrinol Metab; 2020 Jun; 318(6):E881. PubMed ID: 32479159
    [No Abstract]   [Full Text] [Related]  

  • 4. Coronavirus SARS-Cov-2 and arterial hypertension - facts and myths.
    Surma S; Romańczyk M; Łabuzek K
    Pol Merkur Lekarski; 2020 Jun; 48(285):195-198. PubMed ID: 32564046
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Facts and reflections on COVID-19 and anti-hypertensives drugs.
    Marin GH
    Drug Discov Ther; 2020 May; 14(2):105-106. PubMed ID: 32213760
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Could Anti-Hypertensive Drug Therapy Affect the Clinical Prognosis of Hypertensive Patients With COVID-19 Infection? Data From Centers of Southern Italy.
    Sardu C; Maggi P; Messina V; Iuliano P; Sardu A; Iovinella V; Paolisso G; Marfella R
    J Am Heart Assoc; 2020 Sep; 9(17):e016948. PubMed ID: 32633594
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypertension and SARS-CoV-2 infection: is inflammation the missing link?
    Bartoloni E; Perricone C; Cafaro G; Gerli R
    Cardiovasc Res; 2020 Nov; 116(13):e193-e194. PubMed ID: 32966547
    [No Abstract]   [Full Text] [Related]  

  • 8. A Retrospective Study from 2 Centers in China on the Effects of Continued Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers in Patients with Hypertension and COVID-19.
    Wang Z; Zhang D; Wang S; Jin Y; Huan J; Wu Y; Xia C; Li Z; Qi X; Zhang D; Han X; Zhu X; Qu Y; Wang Q
    Med Sci Monit; 2020 Sep; 26():e926651. PubMed ID: 32969367
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decreased Mortality of COVID-19 With Renin-Angiotensin-Aldosterone System Inhibitors Therapy in Patients With Hypertension: A Meta-Analysis.
    Guo X; Zhu Y; Hong Y
    Hypertension; 2020 Aug; 76(2):e13-e14. PubMed ID: 32458694
    [No Abstract]   [Full Text] [Related]  

  • 10. COVID-19 and hypertensive disease in Brazil: possibility of a perfect storm.
    Melo DO; Ribeiro TB; Grezzana GB; Stein AT
    Rev Bras Epidemiol; 2020; 23():e200062. PubMed ID: 32696929
    [No Abstract]   [Full Text] [Related]  

  • 11. Severity of COVID-19: The importance of being hypertensive.
    Angeli F; Masnaghetti S; Visca D; Rossoni A; Taddeo S; Biagini F; Verdecchia P
    Monaldi Arch Chest Dis; 2020 May; 90(2):. PubMed ID: 32432433
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renin-Angiotensin System Inhibition in Cardiovascular Patients at the Time of COVID19: Much Ado for Nothing? A Statement of Activity from the Directors of the Board and the Scientific Directors of the Italian Society of Hypertension.
    Iaccarino G; Borghi C; Cicero AFG; Ferri C; Minuz P; Muiesan ML; Mulatero P; Mulè G; Pucci G; Salvetti M; Savoia C; Sechi LA; Volpe M; Grassi G
    High Blood Press Cardiovasc Prev; 2020 Apr; 27(2):105-108. PubMed ID: 32266708
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atypical Spontaneous Hematomas in a Patient with Severe Coronavirus Disease 2019 (COVID-19).
    Mattioli M; Benfaremo D; Fustini E; Gennarini S
    Semin Thromb Hemost; 2020 Oct; 46(7):856-858. PubMed ID: 32877960
    [No Abstract]   [Full Text] [Related]  

  • 14. Commentary: Obesity: The "Achilles heel" for COVID-19?
    Muscogiuri G; Pugliese G; Barrea L; Savastano S; Colao A
    Metabolism; 2020 Jul; 108():154251. PubMed ID: 32353356
    [No Abstract]   [Full Text] [Related]  

  • 15. Antihypertensive drugs and risk of COVID-19?
    Lo KB; McCullough PA; Rangaswami J
    Lancet Respir Med; 2020 May; 8(5):e29. PubMed ID: 32222167
    [No Abstract]   [Full Text] [Related]  

  • 16. Antihypertensive drugs and risk of COVID-19?
    Tignanelli CJ; Ingraham NE; Sparks MA; Reilkoff R; Bezdicek T; Benson B; Schacker T; Chipman JG; Puskarich MA
    Lancet Respir Med; 2020 May; 8(5):e30-e31. PubMed ID: 32222166
    [No Abstract]   [Full Text] [Related]  

  • 17. Endothelin receptor antagonists for pulmonary arterial hypertension and COVID-19: Friend or foe?
    Badagliacca R; Sciomer S; Petrosillo N
    J Heart Lung Transplant; 2020 Jul; 39(7):729-730. PubMed ID: 32360293
    [No Abstract]   [Full Text] [Related]  

  • 18. Anaphylactic shock following the diagnosis of coronavirus disease 2019.
    Alvarez-Perea A; Baeza ML
    Ann Allergy Asthma Immunol; 2020 Oct; 125(4):477-478. PubMed ID: 32745608
    [No Abstract]   [Full Text] [Related]  

  • 19. Novel Coronavirus (COVID-19)-Associated Guillain-Barré Syndrome: Case Report.
    Rana S; Lima AA; Chandra R; Valeriano J; Desai T; Freiberg W; Small G
    J Clin Neuromuscul Dis; 2020 Jun; 21(4):240-242. PubMed ID: 32453100
    [No Abstract]   [Full Text] [Related]  

  • 20. Thrombus in the right atrium after COVID-19 pneumonia.
    Alcoberro Torres L; Claver Garrido E; Moliner Borja P
    Rev Esp Cardiol (Engl Ed); 2020 Oct; 73(10):845. PubMed ID: 32773347
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.